TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01842282

Amlexanox for Type 2 Diabetes and Obesity

Cause of deathFunding or business, also staffing, sites or logistics Automatic label, confidence 0.6, unverified. How labels are made.
“Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published.”

The sponsor’s own words in the registry.

Life of this trial

2013201420152016201720182019202020212022202320242025Registered2013-04-24Started2013-07-19Stopped2014-02-25Results posted2024-01-17

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
University of Michigan
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus Type 2; Non Alcoholic Fatty Liver Disease; Obesity
Interventions
Amlexanox
Participants
7
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.